Retinoic acid enhances IL-1 beta expression in myeloid leukemia cells and in human monocytes

J Immunol. 1991 Jul 1;147(1):162-7.

Abstract

We have examined the role of retinoic acid (RA), the biologically active metabolite of vitamin A, in expression of the IL-1 beta gene in the human myeloid leukemia cell line THP-1 and in human monocytes. Both protein kinase C-activating phorbol esters, e.g., PMA, and LPS induce IL-1 beta expression in these cells. Physiologic RA concentrations alone were not able to induce any IL-1 beta production, but they strongly enhanced the PMA-induced IL-1 beta protein production and mRNA accumulation in both human monocytes and in THP-1 cells. Nuclear run-off analysis revealed that the enhancing effect was at the transcriptional level. RA also slightly potentiated LPS-induced IL-1 beta expression in THP-1 cells but not in human monocytes. These data suggest that RA can be a strong up-regulator of IL-1 production, but its strength varies depending on the nature of the activating signal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Blotting, Northern
  • Bucladesine / pharmacology
  • Gene Expression / drug effects
  • Humans
  • Interleukin-1 / metabolism*
  • Isoquinolines / pharmacology
  • Leukemia, Myeloid / metabolism*
  • Lipopolysaccharides / pharmacology
  • Monocytes / metabolism*
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors
  • RNA, Messenger / genetics
  • Sulfonamides*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transcription, Genetic / drug effects
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Interleukin-1
  • Isoquinolines
  • Lipopolysaccharides
  • Piperazines
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • Sulfonamides
  • Tretinoin
  • Bucladesine
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • N-(2-guanidinoethyl)-5-isoquinolinesulfonamide
  • Tetradecanoylphorbol Acetate